Dr. Reddys Labs (RDY) Tops Q3 EPS by 19c

Dr. Reddys Labs (NYSE: RDY) reported Q3 EPS of $1.07, $0.19 better than the analyst estimate of $0.88. Revenue for the quarter came in at $828 million versus the consensus estimate of $815.95 million.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Morgan Stanley lifts server market TAM to $809B, boosts targets on compute stocks
• Piper Sandler on Fervo Energy (FRVO): 'Capital Access Supports Potential Upside'